e-learning
resources
London 2016
Tuesday, 06.09.2016
Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Markers of treatment outcome in hypersensitivity pneumonitis patients
Martina Šterclová (Prague, Czech Republic), Martina Sterclova, Martina Kolbekova, Magdalena Smetakova, Martina Vasakova
Source:
International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Session:
Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Session type:
Thematic Poster
Number:
3706
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Martina Šterclová (Prague, Czech Republic), Martina Sterclova, Martina Kolbekova, Magdalena Smetakova, Martina Vasakova. Markers of treatment outcome in hypersensitivity pneumonitis patients. Eur Respir J 2016; 48: Suppl. 60, 3706
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Bronchoalveolar lavage findings and disease progression in hypersensitivity pneumonitis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Clinical and immunological parameters in patients with newly diagnosed sarcoidosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Bronchoalveolar lavage in patients with acute lung toxicity after chemo-radiotherapy for lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003
Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Prognostic impact of bronchoalveolar lavage lymphocytosis in patients with chronic Hypersensitivity Pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Year: 2018
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP)
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013
The value of lymphocytosis in bronchoalveolar lavage in the differential diagnosis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis
Source: Annual Congress 2011 - Work, the environment and respiratory disease
Year: 2011
BAL neutrophilia increases mortality in lung transplant patients despite azithromycin treatment
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013
Induced sputum and BAL from patients with hypersensitivity pneumonitis
Source: Eur Respir J 2001; 18: Suppl. 33, 508s
Year: 2001
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011
Ability of the lung clearance index to monitor progression of early lung disease in children with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Proteological assesment of idiopathic pulmonary fibrosis and hypersensitivity pneumonitis by mean of broncho-alveolar lavage
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Clinical features and outcomes of patients with diffuse alveolar hemorrhage during antithrombotic therapy
Source: International Congress 2014 – ILDs 5
Year: 2014
Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Eosinophilic lung disease
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Histopathological findings of biopsies from patients with extrinsic allergic alveolitis (hipersensitivity pneumonia) in subacute or chronic phase
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept